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Abstract
Background: Early surgery is recommended for asymptomatic severe mitral regurgitation (MR), because of
increased postoperative left ventricular (LV) dysfunction in patients with late surgery. On the other hand, recent
reports emphasized a “watchful waiting” process for the determination of the proper time of mitral valve
surgery. In our study, we compared magnetic resonance imaging (MRI) and transthoracic echocardiography to
evaluate the LV and left atrial (LA) remodeling; for better definitions of patients that may benefit from early
valve surgery.
Methods: Twenty-one patients with moderate to severe asymptomatic MR were evaluated by echocardiography
and MRI. LA and LV ejection fractions (EFs) were calculated by echocardiography and MRI. Pulmonary veins (PVs)
were measured from vein orifices in diastole and systole from the tangential of an imaginary circle that completed
LA wall. Right upper PV indices were calculated with the formula; (Right upper PV diastolic diameter- Right upper
PV systolic diameter)/Right upper PV diastolic diameter.
Results: In 9 patients there were mismatches between echocardiography and MRI measurements of LV EF. LV EFs
were calculated ≥60% by echocardiography, meanwhile < 60% by MRI in these 9 patients. Severity of MR
evaluated by effective regurgitant orifice area (EROA) didn’t differ with preserved and depressed EFs by MRI (p >
0.05). However, both right upper PV indices (0.16 ± 0.06 vs. 0.24 ± 0.08, p: 0.024) and LA EFs (0.19 ± 0.09 vs. 0.33 ±
0.14, p: 0.025) were significantly decreased in patients with depressed EFs when compared to patients with normal
EFs.
Conclusions: MRI might be preferred when small changes in functional parameters like LV EF, LA EF, and PV index
are of clinical importance to disease management like asymptomatic MR patients that we follow up for appropriate
surgery timing.
Introduction
In chronic mitral regurgitation (MR), symptoms do not
develop until decompensation of the left ventricle (LV).
Patients with MR, who are asymptomatic with normal
ventricular performance, will need valve surgery at an
annual rate of 10.3% [1] and early surgery is recom-
mended for asymptomatic severe MR because of
increased postoperative LV dysfunction [2] in patients
with delayed surgery. However, recent reports have
emphasized another process called “watchful waiting”
[3] for relatively low-risk patients.
Mortality after delayed valve surgery is significantly
increased with severe MR (Effective Regurgitant Orifice
Area (EROA) ≥0.4 cm
2)[ 4 ]a n dd e p r e s s e dL Ve j e c t i o n
fraction (EF < 60%). Therefore, timing of the valve surgery
for asymptomatic MR should be based on quantitative
grading of the regurgitation severity and assessment of LV
systolic dysfunction by transthoracic echocardiography [5].
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ior method in evaluating EFs, LA volumes, and pulmon-
ary veins (PVs) [6,7]. Enlarged LA volumes and PVs are
important components of clinical deterioration in
patients with MR; including atrial fibrillation and these
could be subtle markers of early deterioration in asymp-
tomatic patients with moderate to severe MR. In the
present study, we compared cardiac MRI and transthor-
acic echocardiography to evaluate the concealed remo-
deling in LV, LA, and PV; for better definitions of
patients that may benefit from early valve surgery.
Methods
Study population
Forty-six patients who had been under medical follow-
up for moderate to severe MR in our outpatient clinic
were evaluated by transthoracic echocardiography.
Patients were excluded if they had MR due to ischemic
heart disease and if they had an LV EF < 60% by echo-
cardiography. Associated valve diseases such as mitral
stenosis, aortic or tricuspid valve disease and arrhythmia
(including sinus tachycardia) were also accepted as
exclusion criteria. After these exclusion criteria, remain-
ing 38 patients were assessed with respect to New York
Heart Association (NYHA) functional class. Asympto-
matic MR was defined as having functional capacity of
class I or I-II according to patient’sh i s t o r y( N Y H A
Class ≤I-II) and physical examination. Finally, 21
patients with asymptomatic MR were included to the
study analysis. These 21 patients underwent transthor-
acic echocardiography and MRI for further cardiac eva-
luation. Before MRI was performed, all patients were
reevaluated for their NYHA functional Class and physi-
cal examination findings like hypertension, tachycardia,
crepitan ralles and edema; to minimize the hemody-
namic dependent differences. Study protocol was
approved by the local ethics committee and written
informed consent was obtained from all participants.
Echocardiographic Measurements
All patients were evaluated by Sonos 7500 ultrasound
machine (Philips) equipped with 2.5 MHz transducer.
Two-dimensional and Doppler flow parameters were
measured according to American Society of Echocardio-
graphy recommendations [8]. LA volume was calculated
using the area-length technique [9,10] from 4-chamber
and 2-chamber views. LV diameters, volumes, and EFs
were measured as recommended [11]. All images were
analyzed on two occasions by two independent cardiolo-
gists; inter-observer correlation (rho) for maximum
LVEF was 0.95 (p < 0.001) and for LA volume was 0.94
(p < 0.001).
The etiology of MR was determined according to sub-
valvular apparate and mitral valve morphology. The
proximal isovelocity surface area was determined by
measuring proximal-flow convergence [12]. Patient with
an EROA >0.4 cm
2 was accepted as having severe MR,
and >0.2 cm
2 as moderate MR [13]. Standard LV diasto-
lic inflow was obtained in apical 4-chamber view by pla-
cing the sample volume at the valve tips level. Peak
early inflow velocity (E) (m/s), peak atrial inflow velocity
(A) (m/s), and their ratio were determined. Pulmonary
vein (PV) flow velocities were obtained by positioning
the sample volume into the right upper PV approxi-
mately 1 cm above its entry into the LA. Peak systolic
(S) and peak diastolic (D) PV flow velocities were mea-
sured and S/D ratio was calculated. PV flow reversal
duration and the velocity during atrial contraction were
determined [14].
Cardiac Magnetic Resonance Imaging
All MRI studies were acquired with a 1.5-T MRI scan-
ner (Siemens Magnetom, Shymphony, Erlangen) and
evaluated in ARGUS cardiac software (Siemens). For the
evaluation of cardiac functions; images were acquired in
standard planes, which were positioned either parallel to
(horizontal and vertical long-axis planes) or perpendicu-
lar to the long axis of the heart (short-axis planes) [15].
We evaluated MR with standard cardiac planes obtained
with ECG triggering cine gradient echo (GRE) sequences
(FLASH, TrueFISP). Phase images were obtained by
mitral FLASH technique. LV was scanned by consecu-
tive sections at four chambers, long-axis, and short-axis
by cine MRI. LA volumes, LA EFs, and LV EFs were
measured with ARGUS software from the acquired
images. LA EFs were calculated in 20 patients by MRI
with the following formula: (LA end-diastolic volume-
LA end-systolic volume)/LA end-diastolic volume. Axial
and coronal planes were scanned at 6 mm sections by
ECG-gated TrueFISP sequence to identify anatomic
structure of PVs because of the connection and size var-
iations. After determining PV connections at these
images, all PVs [right upper PV, right lower PV, left
upper PV, left lower PV] were displayed separately by
breathold ECG-gated TrueFISP sequence with 5 mm
section thickness (Figure 1). Because of breath dispari-
ties; when these sections did not pass through PVs
properly, we used gap function (shifting the sections for-
wards and backwards only as thick as the interslice gap)
to observe better images of PVs. When crosswise right
upper-left lower PVs or left upper-right lower PVs were
displayed at the same plane; if we considered the image
was adequate, we didn’t obtain additional images. To
standardize these measurements, an imaginary circle
that completed LA wall was drawn and right upper PVs
were measured from the tangential of this circle (Figure
2). These measurements were repeated at the end of
both systole and diastole. Right upper PV indices were
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(Right upper PV diastolic diameter- Right upper PV sys-
tolic diameter)/Right upper PV diastolic diameter as a
sign of atrial compliance. Right and LV volumes were
assessed by ECG-triggered cine sequence and breathhold
technique. The contours were drawn manually. The
relationship between the severity of MR and PV index
was assessed. LA EFs were also evaluated in patients
with both depressed and normal LV EFs. Variability
between the measurements of MRI was evaluated in 12
randomly selected subjects twice by the same observer
and by two independent observers for interobserver and
intraobserver variabilities. The measurements by two
independent observers and by the same observer at dif-
ferent times did not differ in statistically significant
terms (p > 0.05).
Statistical Analysis
Statistical analysis was performed with SPSS 13.0 soft-
ware. All values were expressed as mean ± standard
deviation. Association between PV indices and echocar-
diographic parameters were evaluated with Pearson and
Spearman correlation analysis. P value less than 0.05
was considered as statistically significant. Independent
sample t test was performed to compare means of vari-
ables of groups to determine the statistical significance
of difference. The relationship between echocardiograhic
measurements and MRI measurements was analyzed by
linear regression and Bland Altman analysis (Figure 3).
Results
Baseline characteristics of the patients are shown in
Table 1. The etiology of MR was rheumatic valve dis-
ease in 13 patients and mitral valve prolapse in 6
Figure 1 Demonstration of four pulmonary veins. 1a *Left lower
pulmonary vein. 1b *Right upper pulmonary vein. +Left upper
pulmonary vein. 1c *Right lower pulmonary vein.
Figure 2 Measurement of right upper pulmonary vein index.
Right upper pulmonary vein index: PV diastolic diameter-PV systolic
diameter. PV diastolic diameter.
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Average difference (solid) is shown along with 95% limits of agreement (dashed).
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2 patients. None of the patients had accompanying valve
disease except for mild tricuspid valve regurgitation in
10 patients. Qualitatively assessed MR severity was third
grade in twelve patients. All of the patients were in reg-
ular sinus rhythm with heart rate of 60-90/min. The
mean systolic and diastolic blood pressure values mea-
sured before echocardiography and MRI were not statis-
tically different (122.3 ± 8.9, 77.9 ± 5.1 and 127.7 ± 8.8,
78.0 ± 5.0, respectively, p > 0.05).
Table 2 demonstrates the echocardiographic findings
of the study population. None of the patients had systo-
lic pulmonary artery pressure over 40 mmHg. Mean LA
EF calculated by MRI was 0.27 ± 0.13. Figure 3 shows
the agreement between echocardiography and MRI. The
differences between the two methods were not statisti-
cally significant for LA volume or LV EF. LA volumes
calculated by cardiac MRI were larger than LA volumes
calculated by echocardiography; however the differences
were not statistically significant (p > 0.05) (Figure 4).
There were positive correlations between LA volumes
calculated by echocardiography and cardiac MRI (r:
0.940, p < 0.0001). There was a negative relationship
between EROA and LA EF, but did not reach statisti-
cally significant level (r:-0.412, p: 0.071).
The mean LV EF values measured by echocardiogra-
phy and MRI were not statistically different (0.64 ± 0.03
and 0.61 ± 0.08, respectively, p > 0.05). However, in 9
patients there were mismatches between LV EFs calcu-
lated by these two techniques. In these 9 patients, LV
EFs were determined moderately decreased (<60%) by
cardiac MRI. Besides, there were no significant differ-
ences in EROAs between patients with normal and
depressed EFs determined by MRI (0.27 ± 0.13 cm
2 vs.
0.28 ± 0.18 cm
2,p>0 . 0 5 ) .L AE F sw e r ea l s os i g n i f i -
cantly reduced in patients with depressed LV EFs by
MRI (0.19 ± 0.09 vs. 0.33 ± 0.14, p: 0.025) (Table 3).
There was no correlation between right upper PV
indices and the severity of MR. According to LV EF,
right upper PV indices were found lower in nine
patients who were supposed to be late for mitral valve
surgery (EF < 60%), in comparison with patients with
p r e s e r v e dE F s( 0 . 1 6±0 . 0 6v s .0 . 2 4±0 . 0 8 ,p :0 . 0 2 4 ) .
There was no significant correlation between the veloci-
ties measured with pulse wave Doppler from the right
upper PV (including systolic, diastolic velocities and
the proportion of systolic-diastolic flow velocities: S/D)
and right upper PV index and the other PV indices
(p > 0.05).
Discussion
Despite the increasing tendency for early surgery in the
management of asymptomatic severe MR, watchful wait-
ing is a notable option for some selected patients [3].
Therefore, it is important to differentiate the subgroups
of asymptomatic patients with MR that early surgery
should be considered. This study was designed to find
out if cine MRI could give us more information to eval-
uate this subgroup, i.e. to define patients in this group
Table 1 Characteristics of Patients with Asymptomatic
Mitral Regurgitation (n:21)*
Characteristics
Age (y) 44 ± 16*
Female gender n (%) 15 (71)
Functional capacity, n (%)
NYHA Functional Class I 13 (61)
NYHA Functional Class I-II 8 (38)
Drugs, n (%)
ACE inh. 3 (14)
Beta-Blocking agent 3 (14)
Mitral regurgitation follow-up n (%)
0-6 month 3 (14)
6 months-1 year 3 (14)
1 year< x < 3 years 7 (33)
3 year< x < 6 years 2 (10)
>6 years 6 (29)
* Plus-minus values are means ± SD
† NYHA: New York Heart Association, ACE inh.: Angiotensin Converting
Enzyme Inhibitors
Table 2 Echocardiographic data of patients with mitral
regurgitation (n:21)
Echocardiographic data Mean (min-max)
Left atrium (cm) 4.2 ± 0.7 (3.0-6.0)
Right ventricle (cm) 2.3 ± 0.3 (1.7-2.8)
Left ventricle end-diastole (cm) 4.9 ± 0.4 (4.4-5.9)
Left ventricle end-systole (cm) 3.0 ± 0.4 (2.4-3.8)
Interventricular septum (cm) 1.0 ± 0.1 (0.8-1.3)
Posterior wall (cm) 1.0 ± 0.1 (0.9-1.3)
Mitral E wave velocity (cm/s) 108 ± 28 (67.3-190.0)
Mitral A wave velocity (cm/s) 91.2 ± 30.2 (48.0-156.0)
E/A ratio 1.2 ± 0.3 (0.7-1.7)
Deceleration time (ms) 212 ± 51 (125-300)
Isovolumic relaxation time (ms) 87 ± 32 (55-150)
Left atrial area 1 (cm
2) 21.6 ± 6.3 (13-33)
Left atrial area 2 (cm
2) 20.7 ± 6.8 (12-36)
Left atrial volume (cm
3) 77.3 ± 38.7 (36-169)
Pulmonary vein S wave velocity (cm/s) 58.5 ± 11.0 (45-84)
Pulmonary vein D wave velocity (cm/s) 52.8 ± 13.0 (27 -82)
Pulmonary vein A wave velocity (cm/s) 37.2 ± 9.5 (26.4-64.7)
Pulmonary vein A wave duration (ms) 107.5 ± 18.4 (85-150)
Mitral regurgitation velocity (cm/s) 524.1 ± 98.9 (266-662)
Left ventricle ejection fraction (%) 60 ± 3 (60-70)
SPAP (mmHg) 24.8 ± 5.5 (18-33)
A: Atrial, D: Diastolic, S: Systolic, Left atrial area 1: From four chamber view,
Left atrial area 2: From two chamber view, SPAP: Systolic pulmonary artery
pressure
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couldn’tb ed e t e c t e db ye c h o c a r d i o g r a p h ya tt h et i m eo f
evaluation for surgery decision.
According to the published guidelines; moderately
r e d u c e dL VE F( < 6 0 % )i sa ni n d i c a t o ro fm i t r a lv a l v e
surgery decision in MR [5]. Echocardiography could
sometimes fail in calculating the LV EFs, because of the
3-dimentional enlargement of the ventricle. Similarly; in
9 patients (42%); LV EFs were moderately depressed
(<60%) by MRI, while all LV EFs were preserved (≥60%)
by echocardiographic evaluation. The values of LV EFs
(<60%) published on guidel i n e s[ 5 ]a r eb a s e do ne c h o -
cardiographic results and not on MRI results and for
that reason maybe specific LV EF threshold values by
MRI should be determined as indicators for mitral valve
surgery timing. Lower LA EFs in these 9 patients could
also indicate the ongoing remodeling including both LV
and LA, despite watchful waiting. Additionally, reduced
right upper PV indices might be the indicators of clini-
cal deterioration including atrial fibrillation. Therefore,
MRI should be preferred when small changes in func-
tional parameters are of clinical importance to disease
management like asymptomatic MR that we follow up
for appropriate surgery timing [7,16].
The advantages of MRI over echocardiography are
emphasized by Bellenger at al. as better image quality
and quantification possibilities with high reproducibility
that requires smaller sample sizes to prove statistical sig-
nificance [17]. MRI was suggested to be an accurate and
reproducible method in patients with heart failure that
yields serial assessment of LV remodeling [18]. Westen-
berg et al. searched restrictive annuloplasty results by
Figure 4 Comparison of left atrial volumes calculated by echocardiography and cardiac magnetic resonance imaging.L AV :L e f ta t r i a l
volume. TTE: Transthoracic echocardiography. MRI: Magnetic resonance imaging.
Table 3 Comparison of echocardiography and magnetic resonance imaging (MRI) data according to left ventricle
ejection fractions (LV EFs)
Patients with preserved LV EF (≥60%) in TTE and
depressed EF(<60%) in MRI
Patients with preserved LV EF (≥60%) both in
TTE and MRI
p
n9 1 2
Age (yrs) 50 ± 15 40 ± 16 0.17
LA volume (cm
3) 86.1 ± 47.36 70.36 ± 31.42 0.67
EROA (cm
2) 0.27 ± 0.13 0.28 ± 0.18 0.8
CFA (cm
2) 7.38 ± 2.62 7.20 ± 4.17 0.65
LA EF 0.19 ± 0.09 0.33 ± 0.14 0.025
RUPV index 0.16 ± 0.06 0.24 ± 0.08 0.024
CFA: color flow area, EF: ejection fraction, EROA: effective regurgitant orifice area, LA: left atrium, LV: left ventricle, MRI: magnetic resonance imaging, RUPV: right
upper pulmonary vein, TTE: transthoracic echocardiography.
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remodeling over time using MRI [19]. Since follow-up
studies performed by echocardiography are not optimal
for precise assessment of LA and LV volumes, MRI was
considered to be the gold standard method for assess-
ment of LV function and volumes [20]. On the other
hand, LA volume measurements in MR images were
also shown to be reproducible in clinical practice
according to previous studies [21] and MRI has become
the gold standard for LA volume determination [22-25].
History of mitral valve disease duration sometimes
does not reflect the exact period, because of the long
asymptomatic clinical course of chronic MR. Hence we
defined a new index; PV index that could help to define
both mitral valve disease duration and the severity. All
four PVs could be displayed by MRI and their indices
could be calculated as the components of LA remodel-
ing. In our study, right upper PV diameters were mea-
sured both in diastole and systole by MRI and right
upper PV indices for each patient were calculated. In
nine patients who were supposed to be late for mitral
valve surgery according to LV EFs (LV EF < 60%), right
upper PV indices were found lower by MRI. Although
PV index does not give information about MR severity;
it might reflect the remodeling of LA. LA remodeling is
a consequence of the duration of MR and its severity,
therefore it is an important determinant of hemody-
namic and clinical picture in patients with MR. In a
published study, the comparison of 3 D magnetic reso-
nance angiography with 2 D cine MRI for characterizing
anatomy and size of PV revealed that these two methods
were similar with regard to the evaluation of PVs. In
that study, reduced difference between the PV diameter
at systole and diastole was observed in patients with
atrial fibrillation [26]. Accordingly, reduced right upper
PV index may alert us for a new atrial fibrillation that
originates from PVs and points out a relatively high-risk
subgroup of asymptomatic MR. It is important for
watchful waiting process with MR. After atrial fibrilla-
tion, patients become symptomatic and a new stage
begins with a rapid deterioration of the disease. As this
index is defined for the first time, its thresholds are not
clear yet, but we believe that, randomized clinical trials
with large study populations can determine the thresh-
olds for PV index.
Limitations
The most important limitation of our study is the small
sample size because of using too many exclusion criteria
that could affect our study results. Age was not consid-
ered as eligibility criteria; however age could be an
important factor for PV indices and LA remodeling. PV
index is a novel parameter and a preliminary validation
study could be helpful for this index. Our study could
be improved by following these patients for long-term
mortality and morbidity, but it was not ethical to
observe patients with severe MR and reduced EF deter-
mined by MRI. Therefore, mitral valve surgery was
recommended for these 9 patients with depressed ejec-
tion fractions by MRI.
Conclusion
In asymptomatic patients with MR, the most important
issue is the decision of valve surgery. Despite the new
approaches like watchful waiting process, early surgery
is recommended when valve repair is easy and feasible.
Evaluating asymptomatic MR by MRI is important for
more favorable calculation of LV EF. Reduced LA EFs
and right upper PV indices by MRI, as signs of LA
remodeling might be the predictors of worsening clinical
outcome of asymptomatic MR; including atrial fibrilla-
tion. We believe that, MRI should be preferred when
small changes in functional parameters like LV EF, LA
EF, and PV index are of clinical importance to disease
management like asymptomatic MR that we follow up
for appropriate surgery timing [7,16].
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